July 2008 Br J Cardiol 2008;15:199-204–6
Michael A Scott, Christopher P Price, Martin R Cowie, Martin J Buxton
Introduction Heart failure is a serious syndrome accounting for around 4% of UK general practitioner (GP) consultations in patients over 45 years.1 Diagnosis is complex with frequent co-existing symptoms; misdiagnosis may lead to inappropriate treatment and inefficient use of scarce healthcare resources.2 The National Institute for Health and Clinical Excellence (NICE) guidelines for chronic heart failure state that the 12-lead electrocardiogram (ECG) and/or natriuretic peptides tests (where available) may be used to help exclude heart failure.3 Abnormal ECGs are usually observed in heart failure cases, although in one study, around 20% of pa
January 2008 Br J Cardiol 2008;15:6
Jim Moore
Setting an example The primary care-based heart failure service in Gloucestershire is now four years old and has promising data from its 2006 audit. The audit comprises data from all patients (n=524) with left ventricular systolic dysfunction managed by the service throughout 2006. Results showed all-cause mortality in this high-risk group of only 8.2%, with half of these patients dying at home. In the group of patients who had died during 2006, almost one third had previously discussed and indicated the place they wished to be cared for during the final phase of their illness, with the vast majority opting for home. In over 70% of these case
September 2007 Br J Cardiol 2007;14:221-28
Juliet Usher-Smith, Andy Young, Simon Chatfield, Mike Kirby
Introduction Chronic kidney disease (CKD) is an independent risk factor for cardiovascular disease.1 Almost half of all deaths in patients with CKD are caused by cardiovascular events2 and, in diabetic subjects, mortality increases significantly with reduced kidney function.3 As part of the National Service Framework for Renal Services, CKD was added in February 2006 to the Quality and Outcomes Framework (QOF) for primary care in the UK. Within this, up to 27 points can be earned for the production of a register of patients with stage 3–5 CKD and the appropriate monitoring and treatment of hypertension and prescription of angiotensin-conver
March 2007 Br J Cardiol 2007;14:117-119
Janet McCarlie, Elisabet Reid, Adrian JB Brady
No content available
January 2007 Br J Cardiol 2007;14:51-55
Peter F Tyerman, Gill V Tyerman, Ruth Bacigalupo
No content available
May 2006 Br J Cardiol 2006;13:220-4
Everard W Thornton, Peter Bundred, Michelle Tytherleigh, Ann DM Davies
No content available
March 2006 Br J Cardiol 2006;13:145-52
Simon de Lusignan, Nigel Hague, Jonathan Belsey, Neil Dhoul, Jeremy van Vlymen
No content available
May 2005 Br J Cardiol 2005;12:240-3
Sarah Jarvis
No content available
September 2004 Br J Cardiol 2004;11:408-12
David Wald, Sarah Milne, Richard Chinn, Margaret Martin, Ranjit More
No content available
May 2004
Mike Mead
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits